2Ishikawa M,Yogita S,Miyake H,et al.Clarfication of risk factorsfon hepatectonny in patients with hepatocellular caroinoma.Hepatogastroenterology,2002,49:1625-1631.
2Blom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? [J] Matrix Biol, 2002,21: 473-482.
3Miranda-Diaz A, Rincon AR, Salgado S, et al. Improved effects of viral gene delivery of human uPA plus biliodigestive anastomosis induce recovery from experimental biliary cirrhosis[J]. Mol Ther, 2004,9:30-37.
4Solis-Herruzo JA, de la Torre P, Munoz-Yague MT. Hepatic stellate cells (HSC): architects of hepatic fibrosis[J]. Rev Esp Enferm Dig, 2003, 95: 438-439.
5Safadi R, Friedman SL. Hepatic fibrosis-role of hepatic stellate cell activation[J]. Med Gen Med, 2002,4: 27-30.
6Friedman SL. Liver fibrosis-from bench to bedside[J]. J Hepatol,2003,8(supple1): S38-S53.
7David KS, Alan BW. Liver fibrosis and inflammation. A review[J]. Annals of Hepatol, 2003, 2: 159-163.
8Mehra A, Wrana JL.TGF-beta and the Smad signal transduction pathway[J]. Biochem Cell Biol, 2002,80(5): 605-622.
9Wells RG, Fibrogenesis V. TGF-beta signaling pathways[J]. Am J Physiol Gastrointest Liver Physiol, 2000, 279: G845-G850.
10Heyninck K, Wullaert A, Beyaert R. Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease[J]. Biochem Pharmacol, 2003, 66: 1409-1415.
